News | January 12, 2015

CardioFocus Partners with Japan Lifeline for Distribution of HeartLight Laser Balloon

Japan Lifeline to be exclusive distributor for atrial fibrillation device in country of more than 1 million estimated AF sufferers

CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution

Image courtesy of CardioFocus Inc.

January 12, 2015 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution agreement with Japan Lifeline Co. Ltd. 

AF is the most common sustained arrhythmia and presents elevated risk factors for both stroke and death. It is estimated that more than 1 million people in Japan currently suffer from this debilitating disease. Individuals affected by AF have been increasing worldwide due to an aging population and continued increases in the prevalence and incidence of AF are expected.

Hiroshi Nakagawa, M.D., Ph.D., professor of medicine at the University of Oklahoma Health Sciences Center, director, Clinical Catheter Ablation Program, and director, translational electrophysiology commented:  "While conventional RF ablation technology to treat AF is widely used, it is typical for patients treated with conventional technology to have their arrhythmia recur after one and even after several ablations. The CardioFocus HeartLight is a unique ablation technology that promises to reduce the need for multiple procedures. Its direct endoscopic visualization enables precise placement of ablation energy. This results in the creation of continuous lesions around the pulmonary veins, which are essential for long-lasting elimination of AF. The compliant balloon guarantees an anatomical fit to all types of patient anatomies so the risk of delivering energy too far into the vein and causing complications is minimized. Laser energy creates lesions deep enough to treat the arrhythmia without excess damage to either the endocardial surface or structures surrounding the left atrium. Laser power may also be adjusted to match the differing requirements of various parts of the atrium. This capability increases the efficacy, (durable pulmonary vein isolation) and safety (reduction of collateral damage) for AF ablation procedures."

For more information: www.cardiofocus.com

Related Content

Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018
Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the United States....
Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic...
Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation
News | Ablation Systems | April 12, 2018
Medtronic plc announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance...
Boston Scientific Acquires Securus Medical Group Inc.
News | Ablation Systems | April 04, 2018
Boston Scientific Corp. announced the acquisition of Securus Medical Group Inc., a privately-held company that has...
Overlay Init